The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

26 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.EBI
University of Leeds
(±) cis-Bisamido epoxides: A novel series of potent FXIII-A inhibitors.EBI
University of Leeds
Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.EBI
University of Leeds
The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.EBI
University of Leeds
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.EBI
University of Leeds
Discovery of biphenylacetamide-derived inhibitors of BACE1 using de novo structure-based molecular design.EBI
University of Leeds
Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases.EBI
University of Leeds
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.EBI
University of Leeds
Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.EBI
University of Leeds
Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators.EBI
University of Leeds
design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region.EBI
University of Leeds
Metalloaminopeptidases of the Protozoan Parasite EBI
University of Leeds
From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.EBI
University of Leeds
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis.EBI
University of Leeds
Spatial requirements of the antagonist binding site of the NK2 receptor.EBI
University of Leeds
New insights into the binding mode of pyridine-3-carboxamide inhibitors of E. coli DNA gyrase.EBI
University of Leeds
Identification of an Indazole-Based Pharmacophore for the Inhibition of FGFR Kinases Using Fragment-Led EBI
University of Leeds
Interconvertible geometric isomers of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes.EBI
University of Leeds
Embarking on a Chemical Space Odyssey.EBI
University of Leeds
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.EBI
University of Leeds
Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptorsBDB
Axovant Sciences
Aglaroxin C and derivatives as HCV entry inhibitorsBDB
Sri International
Tricyclic compounds for use as kinase inhibitorsBDB
FundaciÓN Centro Nacional De Investigaciones Oncologicas Carlos Iii
Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moietyBDB
Endorecherche
3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsBDB
Hoffmann-La Roche
Isoindolinone ureas: a novel class of KDR kinase inhibitors.BDB
Abbott Laboratories